Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Personality Disorder
Mental Health
Psychology
Depression
Children's Mental Health
ADHD
Topics

Advertisement

Advertisement

Personality Disorder

Share

Top Latest Popular

Click claims FDA okay for first-in-class schizophrenia DTx pharmaphorum 5d

pharmaphorum 5d

Subtypes of first-episode schizophrenia show varying cognitive impairment Psychiatry Advisor 16:26 Tue, 29 Sep

Psychiatry Advisor 16:26 Tue, 29 Sep

Why earlier conversations about long-acting injectables for schizophrenia matter Medpage Today 15:00 Wed, 30 Sep

Medpage Today 15:00 Wed, 30 Sep

Advertisement

Advertisement

Four deaths prompt FDA safety concerns about novel schizophrenia drug Medpage Today 3d

Medpage Today 3d

PsychAD studies map molecular mechanisms across major brain disorders News-Medical.Net 03:39 Thu, 24 Sep

News-Medical.Net 03:39 Thu, 24 Sep

Alzheimer's Parkinson's Disease

Nighttime light exposure linked to sleep parameters in schizophrenia Psychiatry Advisor 15:57 Wed, 23 Sep

Psychiatry Advisor 15:57 Wed, 23 Sep

Advertisement

Advertisement

Latest

Friday

Decades-Old Schizophrenia Drug Wins Approval for New Formulation Medpage Today 22:33 Fri, 09 Oct

Teva Wins FDA Approval For Once-Monthly Schizophrenia Treatment Weltruza RTT News 14:03 Fri, 09 Oct

Thursday

A Targeted Approach to Schizophrenia Newswise (Press Release) 22:45 Thu, 08 Oct

Four Deaths Prompt FDA Safety Concerns About Novel Schizophrenia Drug Medpage Today 21:27 Thu, 08 Oct

Addex Spin-Out Neurosterix Takes Ntx-253 Closer To Phase 2 Schizophrenia Trial RTT News 12:47 Thu, 08 Oct

Wednesday

Pill Peddling Doc Convicted; Digital Schizophrenia Therapeutic Cleared; AI Anxiety Medpage Today 18:07 Wed, 07 Oct

Tuesday

Click claims FDA okay for first-in-class schizophrenia DTx pharmaphorum 18:18 Tue, 06 Oct

In the last month

Fronto-temporal transcranial direct current stimulation reduces symptoms in treatment-resistant schizophrenia: a randomized sham-controlled trial Nature.com 06:34 Sat, 03 Oct

VA's New Antidepressant Rules; App Aids Schizophrenia; Diet and Depression Medpage Today 19:25 Wed, 30 Sep

Why Earlier Conversations About Long-Acting Injectables for Schizophrenia Matter Medpage Today 15:00 Wed, 30 Sep

Advertisement

Advertisement

Advertisement

Advertisement

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
- Back to Health Mental Health
  - ADHD ADHD
  - Anxiety/Panic/Stress
  - Children's Mental Health
  - Depression Depression
  - Eating Disorders
  - Loneliness Loneliness
  - Men's Mental Health
  - Mindfulness
  - Personality Disorder
  - Psychiatry Psychiatry
  - Psychology Psychology